Press Releases Items Per Page 102550 Year None2023202220212020201920182017201620152014201320122011201020092008 February 22, 2021 Revance Appoints Biotech and Pharmaceutical Executive, Olivia C. Ware, and Fintech and Payments Thought Leader and Entrepreneur, Carey O’Connor Kolaja, to its Board of Directors February 12, 2021 Revance to Release Fourth Quarter and Full Year 2020 Financial Results on Monday, February 22, 2021 January 25, 2021 Revance to Highlight Aesthetic Clinical Data on DaxibotulinumtoxinA for Injection and Hyaluronic Acid Filler Study Results at Maui Derm for Dermatologists 2021 January 22, 2021 Revance Issues Inaugural Environmental, Social and Governance (ESG) Report January 19, 2021 Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) January 7, 2021 Revance to Participate in the 39th Annual J.P. Morgan Healthcare Conference January 7, 2021 Revance Provides Corporate Update and Anticipated Milestones for 2021 December 22, 2020 Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection December 21, 2020 Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 17, 2020 Revance Reports Positive Efficacy and Duration Results from Phase 2 Upper Facial Lines Study Pagination First page « first Previous page ‹ previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page next › Last page last » Displaying 61 - 70 of 298